| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NG.2287 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/ng.2287 |
| P932 | PMC publication ID | 3619412 |
| P698 | PubMed publication ID | 22641210 |
| P5875 | ResearchGate publication ID | 225068992 |
| P50 | author | Elaine Mardis | Q5353251 |
| Ching-Hon Pui | Q66385450 | ||
| P2093 | author name string | Li Ding | |
| Richard K Wilson | |||
| Jinghui Zhang | |||
| Timothy J Ley | |||
| William E Evans | |||
| James R Downing | |||
| P2860 | cites work | Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project | Q21061203 |
| The genetic basis of early T-cell precursor acute lymphoblastic leukaemia | Q24601515 | ||
| A map of human genome variation from population-scale sequencing | Q24617794 | ||
| Distant metastasis occurs late during the genetic evolution of pancreatic cancer | Q24624284 | ||
| Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas | Q24629777 | ||
| An integrated genomic analysis of human glioblastoma multiforme | Q24648860 | ||
| Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 | ||
| Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin | Q27851546 | ||
| Cancer statistics, 2012 | Q27860574 | ||
| Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma | Q29616862 | ||
| The patterns and dynamics of genomic instability in metastatic pancreatic cancer | Q29618121 | ||
| Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer | Q33865946 | ||
| CREBBP mutations in relapsed acute lymphoblastic leukaemia | Q34792792 | ||
| Challenging issues in pediatric oncology | Q35602419 | ||
| Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies | Q35667279 | ||
| CREST maps somatic structural variation in cancer genomes with base-pair resolution. | Q36480006 | ||
| Association of age at diagnosis and genetic mutations in patients with neuroblastoma. | Q36480024 | ||
| Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. | Q37351577 | ||
| Computational methods for discovering structural variation with next-generation sequencing | Q37618538 | ||
| A novel retinoblastoma therapy from genomic and epigenetic analyses | Q39413689 | ||
| Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. | Q51890946 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 619-622 | |
| P577 | publication date | 2012-05-29 | |
| P1433 | published in | Nature Genetics | Q976454 |
| P1476 | title | The Pediatric Cancer Genome Project | |
| P478 | volume | 44 |
| Q93147892 | 11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood |
| Q37166753 | A 50-year journey to cure childhood acute lymphoblastic leukemia |
| Q92314685 | A Key Role for the Ubiquitin Ligase UBR4 in Myofiber Hypertrophy in Drosophila and Mice |
| Q26866379 | A health-care system perspective on implementing genomic medicine: pediatric acute lymphoblastic leukemia as a paradigm |
| Q35061962 | Accurate detection of subclonal single nucleotide variants in whole genome amplified and pooled cancer samples using HaloPlex target enrichment |
| Q36541505 | An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia |
| Q35974493 | An integrated analysis tool for analyzing hybridization intensities and genotypes using new-generation population-optimized human arrays |
| Q37146303 | Analysis of Patterns of Gene Expression Variation within and between Ethnic Populations in Pediatric B-ALL |
| Q40262230 | Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival |
| Q30397544 | CONSERTING: integrating copy-number analysis with structural-variation detection |
| Q35470624 | Cancer-associated mutants of RNA helicase DDX3X are defective in RNA-stimulated ATP hydrolysis |
| Q42770457 | Cell context in the control of self-renewal and proliferation regulated by MLL1. |
| Q49679684 | Cell death-based treatment of childhood cancer. |
| Q28087637 | Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration |
| Q38083799 | Chromatin remodeling defects in pediatric and young adult glioblastoma: a tale of a variant histone 3 tail |
| Q59129106 | Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome |
| Q59126293 | Clonal dynamics in osteosarcoma defined by RGB marking |
| Q47128107 | Comparison of genome sequencing and clinical genotyping for pharmacogenes |
| Q94554231 | Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors |
| Q35692614 | Cross-Species Genomics Identifies TAF12, NFYC, and RAD54L as Choroid Plexus Carcinoma Oncogenes |
| Q38094131 | Diagnostic cancer genome sequencing and the contribution of germline variants |
| Q91341516 | Differentiation of human pluripotent stem cells into neurons or cortical organoids requires transcriptional co-regulation by UTX and 53BP1 |
| Q36262295 | Drug discovery in paediatric oncology: roadblocks to progress |
| Q35903049 | Emergency medical genomes: a breakthrough application of precision medicine |
| Q38866662 | Epigenetic control of gene expression in leukemogenesis: Cooperation between wild type MLL and MLL fusion proteins |
| Q90179438 | Exercise as a Potential Intervention to Modulate Cancer Outcomes in Children and Adults? |
| Q36967018 | Exploring genomic alteration in pediatric cancer using ProteinPaint |
| Q38195612 | From genes to health - challenges and opportunities |
| Q26827640 | From human genome to cancer genome: the first decade |
| Q36174146 | Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia |
| Q35836071 | Genome Modeling System: A Knowledge Management Platform for Genomics |
| Q42680626 | Genome-wide network analysis of Wnt signaling in three pediatric cancers. |
| Q47133585 | Genome-wide segregation of single nucleotide and structural variants into single cancer cells |
| Q33701435 | Genomic analysis and clinical management of adolescent cutaneous melanoma |
| Q37359118 | Genomic characterization of childhood acute lymphoblastic leukemia |
| Q92709283 | Genomic subtyping and therapeutic targeting of acute erythroleukemia |
| Q58804574 | Genomics of adult and pediatric solid tumors |
| Q47122725 | Germline BRCA2 mutations detected in pediatric sequencing studies impact parents' evaluation and care |
| Q33423823 | Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia |
| Q64083344 | Germline deletion of in familial acute lymphoblastic leukemia |
| Q50061542 | Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium. |
| Q34157264 | Growing up in the genomic era: implications of whole-genome sequencing for children, families, and pediatric practice |
| Q51758996 | HNRNPH1 is required for rhabdomyosarcoma cell growth and survival. |
| Q54257595 | Harnessing massively parallel DNA sequencing for the personalization of cancer management. |
| Q35801603 | High rates of submicroscopic aberrations in karyotypically normal acute lymphoblastic leukemia. |
| Q33798544 | Identification of a novel functional JAK1 S646P mutation in acute lymphoblastic leukemia |
| Q89517131 | Immunotherapy of Pediatric Solid Tumors: Treatments at a Crossroads, with an Emphasis on Antibodies |
| Q112703882 | Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization |
| Q98947319 | Integrative genomic analyses reveal mechanisms of glucocorticoid resistance in acute lymphoblastic leukemia |
| Q38938719 | Lessons from Retinoblastoma: Implications for Cancer, Development, Evolution, and Regenerative Medicine |
| Q89722611 | MYCN amplification and ATRX mutations are incompatible in neuroblastoma |
| Q33762835 | Management of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. |
| Q35712405 | Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response |
| Q50980884 | Medicine. (Poly)combing the pediatric cancer genome for answers. |
| Q36700543 | Medulloblastoma biology in the post-genomic era. |
| Q48023007 | Molecular Basis of Pediatric Brain Tumors |
| Q37643136 | Molecular therapeutic approaches for pediatric acute myeloid leukemia |
| Q28300353 | Mutational landscape and significance across 12 major cancer types |
| Q37592751 | NF-kappa B mediated up-regulation of CCCTC-binding factor in pediatric acute lymphoblastic leukemia |
| Q44360875 | Natural killer cell therapy for cancer: delivering on a promise |
| Q43529524 | New drugs for children and adolescents with cancer: the need for novel development pathways. |
| Q64064714 | New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx |
| Q38084015 | New policies to address the global burden of childhood cancers |
| Q38947409 | Next-Generation Sequencing and the Return of Results |
| Q51032285 | Next-Generation Sequencing. |
| Q38653083 | Osteosarcoma: Molecular Pathogenesis and iPSC Modeling |
| Q39022681 | Overcoming challenges to meaningful informed consent for whole genome sequencing in pediatric cancer research. |
| Q37729676 | Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge |
| Q52729895 | Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours. |
| Q92401921 | Patient-Driven Discovery, Therapeutic Targeting, and Post-Clinical Validation of a Novel AKT1 Fusion-Driven Cancer |
| Q92795381 | Pediatric Cancer Variant Pathogenicity Information Exchange (PeCanPIE): a cloud-based platform for curating and classifying germline variants |
| Q36163029 | Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? |
| Q36259607 | Pediatric cancer epigenome and the influence of folate |
| Q27023560 | Pediatric solid tumor genomics and developmental pliancy |
| Q35740537 | Pedican: an online gene resource for pediatric cancers with literature evidence |
| Q38076107 | Personalized immune-interception of cancer and the battle of two adaptive systems--when is the time right? |
| Q26849582 | Peto's paradox and the hallmarks of cancer: constructing an evolutionary framework for understanding the incidence of cancer |
| Q91238301 | Pharma-Oncogenomics in the Era of Personal Genomics: A Quick Guide to Online Resources and Tools |
| Q34297575 | Pharmacogenomics and individualized medicine: translating science into practice |
| Q47392557 | Precision medicine in pediatric oncology |
| Q57384544 | Precision medicine in pediatric oncology |
| Q38810911 | Precision medicine in pediatric oncology: Lessons learned and next steps |
| Q36378105 | Preclinical Models Provide Scientific Justification and Translational Relevance for Moving Novel Therapeutics into Clinical Trials for Pediatric Cancer |
| Q36924325 | Primary intracranial soft tissue sarcomas in children, adolescents, and young adults: single institution experience and review of the literature |
| Q42714012 | Proceedings of the 12th Annual UT-ORNL-KBRIN Bioinformatics Summit 2013 |
| Q90326654 | Profiling targetable immune checkpoints in osteosarcoma |
| Q37041787 | Raising Genomic Citizens: Adolescents and the Return of Secondary Genomic Findings |
| Q35917978 | Rapid cloning, expression, and functional characterization of paired αβ and γδ T-cell receptor chains from single-cell analysis. |
| Q34354839 | Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma |
| Q34413741 | Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. |
| Q40262308 | Replication stress, DNA damage signalling, and cytomegalovirus infection in human medulloblastomas |
| Q42363061 | Resources for Interpreting Variants in Precision Genomic Oncology Applications |
| Q42371491 | SOX7 promotes the maintenance and proliferation of B cell precursor acute lymphoblastic cells. |
| Q35202350 | Safety and diagnostic accuracy of tumor biopsies in children with cancer |
| Q38844223 | Sequencing-based diagnostics for pediatric genetic diseases: progress and potential |
| Q34786551 | Simultaneous targeting of PI3Kδ and a PI3Kδ-dependent MEK1/2-Erk1/2 pathway for therapy in pediatric B-cell acute lymphoblastic leukemia |
| Q40310625 | SomamiR 2.0: a database of cancer somatic mutations altering microRNA-ceRNA interactions. |
| Q36491386 | SomamiR: a database for somatic mutations impacting microRNA function in cancer. |
| Q26770333 | Spanning the genomics era: the vital role of a single institution biorepository for childhood cancer research over a decade |
| Q26991436 | Structural variation discovery in the cancer genome using next generation sequencing: computational solutions and perspectives |
| Q47951881 | Targeted Sequencing of Malignant Supratentorial Pediatric Brain Tumors Demonstrates a High Frequency of Clinically Relevant Mutations. |
| Q38659292 | Targeted molecular radiotherapy of pediatric solid tumors using a radioiodinated alkyl-phospholipid ether analog |
| Q104073619 | Targeting aurora kinases as a potential prognostic and therapeutical biomarkers in pediatric acute lymphoblastic leukaemia |
| Q35897778 | The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 Alleles |
| Q38864787 | The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities |
| Q47566135 | The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis. |
| Q35253526 | The UCSC Cancer Genomics Browser: update 2015 |
| Q55283055 | The critical role that STAT3 plays in glioma-initiating cells: STAT3 addiction in glioma. |
| Q53700123 | The emerging clinical relevance of genomics in cancer medicine. |
| Q38782082 | The future of academic haematology |
| Q37574743 | The genomic landscape of hypodiploid acute lymphoblastic leukemia |
| Q36406411 | The glucose-sensing transcription factor MLX promotes myogenesis via myokine signaling |
| Q50421569 | The landscape of genomic alterations across childhood cancers. |
| Q34414087 | The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes. |
| Q34465221 | The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias |
| Q38601828 | The neoepitope landscape in pediatric cancers. |
| Q39170500 | The promise of Janus kinase inhibitors in the treatment of hematological malignancies |
| Q50073898 | The role of interleukin-2, all-trans retinoic acid, and natural killer cells: surveillance mechanisms in anti-GD2 antibody therapy in neuroblastoma. |
| Q24296476 | The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability |
| Q64051911 | Tissue-specific alteration of gene expression and function by RU486 and the GeneSwitch system |
| Q64296260 | Tumor Variant Identification That Accounts for the Unique Molecular Landscape of Pediatric Malignancies |
| Q61442962 | USP19 deubiquitinates EWS-FLI1 to regulate Ewing sarcoma growth |
| Q61447884 | Use case driven evaluation of open databases for pediatric cancer research |
| Q91968472 | VCF2CNA: A tool for efficiently detecting copy-number alterations in VCF genotype data and tumor purity |
| Q57817762 | Whole genomes, small children, big questions |
| Q37055286 | Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas |
| Q89802562 | [Osteoid-forming bone tumors : Morphology and current translational cell biology] |
Search more.